27.30 +0.24 (0.89%)
After hours: 7:40PM EDT
|Bid||0.00 x 800|
|Ask||0.00 x 1800|
|Day's Range||25.88 - 27.16|
|52 Week Range||0.52 - 39.72|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.79%|
“Wonder Women Of Weed” is a show co-hosted by Javier Hasse and Adelia Carrillo, featuring accomplished female leaders in the cannabis industry. #WWoW is brought to you by a collaborative effort that includes Benzinga, Industry Power Women and Direct Cannabis Network. Tahira Rehmatullah is one of those inherently impressive people.
The company’s losses are similar to those of Aphria (APHQF), Supreme Cannabis (SPRWF), and Aurora Cannabis (ACBFF). The current consensus price target for CannTrust was 14.3 Canadian dollars, which declined from 14.5 Canadian dollars a month ago.
California, a state that was seen as a potential help to MJ and marijuana equities, is playing a part in the exchange traded fund's woes. California was one of the first states to legalize marijuana for medicinal use. The largest U.S. state followed that up on Election Day 2016 by finally voting to legalize marijuana for recreational use.
Aurora Cannabis stock (ACB) (ACBFF) has had a terrible performance over the last month. It is easy to see why investors are staying away from the cannabis sector (MJ) including Aphria (APHQF) and Cronos Group (CRON), both of which are down in the double digits YTD. The consensus rating on Aurora Cannabis is unchanged from last month.
The Global Cannabis Stock Index struck a 2018 low as it fell 10 percent in July. Pharmacies in Italy were given a green light to sell medical cannabis. “I will make every effort to ensure that medical cannabis is available in all pharmacies to ensure the continuity of treatment to which you are entitled,” Health Minister Giulia Grillo said on Facebook.
In the United States, cannabis legalization has moved at an incremental pace, with individual states adopting different approaches to marijuana for either medical or recreational purposes, or both. While advocates continue to push for nationwide legalization, even the piecemeal road to legal cannabis that has already developed has generated a sizable new industry. For many investors, the idea of a regulated, legal marijuana industry suggests ample new opportunities for investment and growth.
Felony charges against six people arrested in the raid of a Detroit marijuana grow operation with a reported $1 million in plants were dismissed Tuesday by a judge who said the facility was within the bounds of its temporary state license. The building at 4473 W. Jefferson Ave. is owned by former NBA player-turned-cannabis entrepreneur Al Harrington, who’s said he believes the raid amounts to harassment of a minority-owned business. The grow op’s certificate of occupancy from the city stated the intent for a greenhouse at the site, and the operation holds a temporary Class C license under Michigan’s Medical Marihuana Facilities Licensing Act allowing up to 1,500 plants, said 36th District Court Judge Kenneth King.
Pennsylvania’s chief fiscal officer called Thursday for the state to tax and regulate marijuana. “As Philadelphia and Pittsburgh have demonstrated, decriminalizing marijuana saves millions in court costs alone,” DePasquale said in his report. Fresh economic interest in cannabis — particularly from a state that has legalized only medical marijuana, with just seven cities having decriminalized possession altogether — is a positive for the greater U.S. decriminalization movement.
In the second half of this year, much of cannabis companies’ efforts will go into organizing the logistics of the business. Companies will continue to make capital investments in capacity extension, value addition, marketing and distribution, and other areas. In the above chart, we’ve outlined four stages in the cannabis value chain.
Medical marijuana sales continue to slide in Colorado. For the first half of 2018, revenue fell 21 percent year-over-year to $165.8 million. Recreational sales rose 14 percent to $573 million. Total combined ...
Earlier this year, Benzinga published an article looking into ways of consuming cannabis that didn't involve smoking. The cannabis industry has evolved beyond simply eliminating the risks associated with smoking or solving the issue of inconsistent dosing in edibles to address more complex problems like the degradation of certain molecules during extraction, activation or infusion processes. How can patients obtain the complete spectrum of medical properties the cannabis plant has to offer?
Unlike Canopy Growth (CGC) (WEED), Aurora Cannabis (ACB) (ACBFF) has not reported its recent earnings and has not announced its upcoming earnings date. The impact of these two companies will be something to watch whenever the company releases its earnings. To learn more about the acquisition, read MedReleaf Stock Rises on Aurora Cannabis Acquisition. It had a consensus price target of 9.63 Canadian dollars and a median price target of 9.50 Canadian dollars.
Last week, marijuana exchange-traded funds (ETFs) and stocks rallied after Canada legalized recreational marijuana. Not only did Canada legalize recreational marijuana, that country is home to more marijuana ETFs than are listed here in the U.S. For the time being, the universe of U.S. marijuana ETFs is sparsely populated.
Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Ahead of the conference, we’re interviewing the speakers who will deliver key insights on the cannabis space at the BZ Cannabis Capital Conference. This installment features Harrison Phillips with Viridian Capital Advisors. Quickly give us your background—why are you passionate about cannabis?
In reality, investors do not make outsized returns by buying stocks like Apple Inc (NASDAQ:AAPL) or Amazon.com, Inc. (NASDAQ:AMZN) at their current sizes. Fortunately, several up-and-coming stocks have appeared that will allow investors to profit from this growth and change. This revolution is more of an attitudinal change which has brought the market numerous up-and-coming stocks.
After Canopy Growth (CGC)(WEED) reported its fourth-quarter earnings results yesterday, its stock fell ~10% during trading hours. However, the stock received a price target upgrade from Cowen, which raised its price target to 48 Canadian dollars from 45 Canadian dollars. Cowen has rated CCG as “outperform.” Let’s see how this compares with other ratings.
Intraday pricing on the funds means arbitrageurs make the money at the expense of individual investorsEverett CollectionInvesting as gambling. Some may wonder why iconic active money manager Warren Buffett likes to tell people to buy low-cost index funds to participate in the stock market. While on the surface ETFs may look superior to index funds because of this intraday pricing — and, hence, they have seen massive growth, to the tune of $3.6 trillion in assets in the U.S. and much bigger globally (see chart) — under the surface, this intraday pricing “advantage” of ETFs can get really ugly.
Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Ahead of the conference, we’re interviewing the speakers who will deliver key insights on the cannabis space at the BZ Cannabis Capital Conference.
The U.S. Food and Drug Administration has approved a cannabis-derived prescription medicine for the first time in the country’s history. Epidiolex, a childhood epilepsy drug developed by British company GW Pharmaceuticals ( GWPH), contains cannabidiol (CBD), one of the many chemical compounds found in marijuana plants.
Cannabis producers (MJ) have ramped up their production capacities to meet the anticipated demand for cannabis, as we saw in our series How Cannabis Companies Are Rushing to Expand Operations. In the coming months, we expect merger and acquisition activities to stay active. Acquisitions will provide us with a perspective on the anticipated market dynamics, which will be a key to growth drivers.
Today ETF Managers Group paid distributions to shareholders of record on June 20, 2018 for the following exchange-traded funds:
Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Ahead of the conference, we’re interviewing the speakers who will deliver key insights on the cannabis space at the BZ Cannabis Capital Conference. This installment features New Cannabis Ventures founder Alan Brochstein. Quickly give us your background—why are you passionate about cannabis?
The outlook for the marijuana industry has brightened after Canada legalized nationwide recreational use of cannabis. Here are two ETFs to tap the boom.
Marijuana stocks rose Wednesday after Canada's lawmakers approved legislation to fully legalize cannabis, which is already spurring activity for new stock listings.